Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Crohn Disease »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Critical Pathways < Crohn Disease < Cross Infection  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000447 (2019) Juan Shan [République populaire de Chine] ; Jiabi Zhang [République populaire de Chine]Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis.
000586 (2019) Théo Willeman [France] ; Jean-François Jourdil [France] ; Elodie Gautier-Veyret [France] ; Bruno Bonaz [France] ; Françoise Stanke-Labesque [France]A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn's disease.
000D50 (2016) Marc Uemura [États-Unis] ; Van A. Trinh [États-Unis] ; Cara Haymaker [États-Unis] ; Natalie Jackson [États-Unis] ; Dae Won Kim [États-Unis] ; James P. Allison [États-Unis] ; Padmanee Sharma [États-Unis] ; Luis Vence [États-Unis] ; Chantale Bernatchez [États-Unis] ; Patrick Hwu [États-Unis] ; Adi Diab [États-Unis]Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease: a case report.
000D84 (2016) Laisy Zacarías Martínez [Espagne] ; Lourdes Mateo Soria [Espagne] ; Míriam Ma Osa Círia [Espagne] ; Ariadna Clos Parals [Espagne] ; Eduard Cabré Gelada [Espagne] ; Eugeni Domènech Morral [Espagne]Poor correlation between acute phase reactants and intestinal involvement in patients with onset of Crohn's disease under treatment with an interleukin-6 inhibitor due to seronegative arthropathy.
000E37 (2016) Coline Faivre [France] ; Axel Patrice Villani [France] ; François Aubin [France] ; Dan Lipsker [France] ; Martine Bottaro [France] ; Jean-David Cohen [France] ; François Durupt [France] ; Géraldine Jeudy [France] ; Emilie Sbidian [France] ; Eric Toussirot [France] ; Valérie Badot [Belgique] ; Sébastien Barbarot [France] ; Sébastien Debarbieux [France] ; Emmanuel Delaporte [France] ; Guetty Goegebeur [France] ; Jacques Morel [France] ; Aude Nassif [France] ; Gérard Duru [France] ; Denis Jullien [France]Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.
001480 (2013) A. Ca As-Ventura ; E. Rodríguez ; M. Andreu ; L. MárquezTocilizumab in amyloidosis-associated kidney disease secondary to inflammatory bowel diseases.
001783 (2012) Yifei Liu [États-Unis] ; Eric Q. Wu ; Arielle G. Bensimon ; Chun-Po Steve Fan ; Yanjun Bao ; Arijit Ganguli ; Mei Yang ; Mary Cifaldi ; Parvez MulaniCost per responder associated with biologic therapies for Crohn's disease, psoriasis, and rheumatoid arthritis.
001979 (2010) Laure Brulhart ; Michael J. Nissen ; Paola Chevallier ; Cem GabayTocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists.
001B41 (2008) Yasuo Adachi [Japon] ; Naoko Yoshio-Hoshino ; Norihiro NishimotoThe blockade of IL-6 signaling in rational drug design.
001C12 (2006) Norihiro Nishimoto [Japon] ; Tadamitsu KishimotoInterleukin 6: from bench to bedside.
001C15 (2006) Changhai Ding [Australie] ; Graeme JonesAnti-interleukin-6 receptor antibody treatment in inflammatory autoimmune diseases.
001C20 (2005) Norihiro Nishimoto[Anti-IL-6 receptor antibody].
001C28 (2005) Norihiro Nishimoto [Japon]Clinical studies in patients with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan.
001C32 (2003) Changhai Ding [Australie] ; Graeme JonesTechnology evaluation: MRA, Chugai.
001E08 (????) Adith Venkiteshwaran [États-Unis]Tocilizumab.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Crohn Disease" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Crohn Disease" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Crohn Disease
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021